ATLAS Trademark
ATLAS is a USPTO trademark filed by Aignostics GmbH. Status: Pending.
Trademark Facts
| Mark | ATLAS |
|---|---|
| Serial Number | 99023400 |
| Status | Pending |
| Filing Date | 2025-01-30 |
| Mark Type | Word |
| Nice Classes | 009 (Electronics & Software), 042 (Software & IT), 044 (Medical Services) |
| Owner | Aignostics GmbH |
| Attorney of Record | Leesa N. Weiss |
| Prosecution Events | 19 |
| Latest Event | GNSL on 2026-03-02 |
Goods & Services
Downloadable software using artificial intelligence and machine learning for providing and facilitating medical diagnosis, for managing and analysing medical data, and for managing data and physician and patient communications related to clinical trials, and for managing data and communications of pharmaceutical, scientific, biological and clinical research, all of the foregoing for use in the fields of pathology, medical research, drug discovery and development; downloadable software for the integration of artificial intelligence and machine learning in the field of medical data; Medical diagnostic testing services; medical analysis services for cancer diagnosis and prognosis; medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; all the above services using artificial intelligence and machine learning; Development of software in the field of artificial intelligence technology for the analysis of medical data; research in the field of artificial intelligence technology for the analysis of medical data; providing temporary use of online non-downloadable computer programs using artificial intelligence for the analysis of medical data; Software as a service (SAAS) featuring software for processing, diagnosing and analyzing medical data using machine learning algorithms and artificial intelligence; AI-software based analysis of human tissues for medical research; AI-software based analysis of human serum for medical research; AI-software based medical and pharmacological research services; provision of information and data relating to AI-software based medical research; AI-software based clinical research in the fields of pathology, histology, oncology, and drug discovery and development; AI-software based medical and scientific research, namely, conducting clinical trials for others; biological research, clinical research in the fields of pathology, histology, oncology, drug discovery, drug development and medical research, all AI-software based; AI-software based scientific research in the nature of conducting clinical trials for others for pharmaceutical products